In another prostate cancer cell line DU-145, we also observed that siRNA knockdown of EZH2 or DZNeP treatment increased miR-31 expression and decreased E2F6 (Supplementary Figures 1A and B). The gene discussed is EZH2; the disease is prostate carcinoma.